Canada markets closed

Aligos Therapeutics, Inc. (ALGS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.7303-0.0462 (-5.95%)
At close: 04:00PM EDT
0.7500 +0.02 (+2.70%)
After hours: 05:16PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-99,587
-87,679
-96,046
-128,332
-108,543
Depreciation & amortization
2,899
3,069
3,675
3,778
3,325
Stock based compensation
11,636
12,652
14,693
13,457
2,975
Change in working capital
-11,346
-9,525
-1,552
-4,651
16,063
Accounts Payable
21
-2,219
1,722
-313
-130
Other working capital
-79,437
-79,016
-80,332
-116,554
-76,327
Other non-cash items
-
-
-
-
11,387
Net cash provided by operating activites
-79,356
-78,997
-79,389
-115,662
-74,263
Cash flows from investing activities
Investments in property, plant and equipment
-81
-19
-943
-892
-2,064
Purchases of investments
-88,584
-11
-104,265
-19,086
-45,281
Sales/Maturities of investments
25,011
45,011
78,915
23,000
80,100
Net cash used for investing activites
-63,654
44,981
-26,293
3,022
32,755
Cash flows from financing activities
Debt repayment
-91
-96
-61
-79
-58
Common stock issued
-
17,443
0
78,584
155,542
Other financing activites
-
-
-
-875
-4,521
Net cash used privided by (used for) financing activities
88,310
88,328
164
78,677
192,348
Net change in cash
-54,700
54,312
-105,518
-33,963
150,840
Cash at beginning of period
79,068
81,462
186,980
220,943
70,103
Cash at end of period
24,368
135,774
81,462
186,980
220,943
Free Cash Flow
Operating Cash Flow
-79,356
-78,997
-79,389
-115,662
-74,263
Capital Expenditure
-81
-19
-943
-892
-2,064
Free Cash Flow
-79,437
-79,016
-80,332
-116,554
-76,327